
(in millions of U.S. Dollars)	March 27, 2022	June 27, 2021
Billed trade receivables	$120.6	$95.6
Unbilled contract receivables	2.1	0.6
Royalties	0.7	0.5
	123.4	96.7

Allowance for bad debts	(1.0)	(0.8)
Accounts receivable, net	$122.4	$95.9


(in millions of U.S. Dollars)			March 27, 2022
Balance at beginning of period			$0.8
Current period provision change			0.2
Write-offs, net of recoveries			—
Balance at end of period			$1.0


(in millions of U.S. Dollars)	March 27, 2022	June 27, 2021
Raw material	$52.7	$43.3
Work-in-progress	146.0	109.5
Finished goods	20.7	13.8
Inventories	$219.4	$166.6


(in millions of U.S. Dollars)	March 27, 2022	June 27, 2021
Reimbursement receivable on long-term incentive agreement	$153.7	$4.6
Accrued interest receivable	4.4	5.5
Receivable on Wafer Supply Agreement	2.4	7.0
Inventory related to Wafer Supply Agreement	3.3	3.9
Deferred product costs	2.5	1.8
Other	3.0	5.1
Other current assets	$169.3	$27.9


(in millions of U.S. Dollars)	March 27, 2022	June 27, 2021
Accounts payable, trade	$54.1	$44.2
Accrued salaries and wages	79.9	69.5
Accrued property and equipment	88.3	248.3
Accrued expenses	21.0	17.4
Other	5.0	1.7
Accounts payable and accrued expenses	$248.3	$381.1


	Three months ended		Nine months ended
(in millions of U.S. Dollars)	March 27, 2022	March 28, 2021	March 27, 2022	March 28, 2021
Factory optimization restructuring	$0.8	$3.8	$5.5	$6.7

Severance and other restructuring	0.5	0.6	0.5	3.4
Total restructuring costs	1.3	4.4	6.0	10.1
Project, transformation and transaction costs	1.2	2.4	5.3	3.7
Factory optimization start-up costs	21.4	1.8	41.0	6.0

Non-restructuring related executive severance	—	2.8	—	2.8

Other operating expense	$23.9	$11.4	$52.3	$22.6

Accumulated other comprehensive (loss) income, net of taxes, consisted of $18.0 million of net unrealized losses on available-for-sale securities and $2.7 million of net unrealized gains on available-for-sale securities as of March 27, 2022 and June 27, 2021, respectively. Amounts for both periods include a $2.4 million loss related to tax on unrealized loss on available-for-sale securities.

Reclassifications out of accumulated other comprehensive (loss) income were a less than $0.1 million gain and a $0.3 million gain for the three and nine months ended March 27, 2022, respectively, and a $0.1 million gain and a $0.3 million gain for each of the three and nine months ended March 28, 2021, respectively. Amounts were reclassified to non-operating expense, net on the consolidated statements of operations.

Additionally, for the three and nine months ended March 28, 2021, $9.5 million of currency translation gain was reclassified to loss on sale of discontinued operations within net loss on discontinued operations on the consolidated statements of operations.


	Three months ended		Nine months ended
(in millions of U.S. Dollars)	March 27, 2022	March 28, 2021	March 27, 2022	March 28, 2021
Foreign currency gain, net	($0.3)	($0.1)	($0.6)	($2.5)
Gain on sale of investments, net	—	(0.1)	(0.3)	(0.3)
Loss on debt extinguishment (1)	—	—	24.8	—

Gain on equity investment, net	—	(0.9)	—	(7.9)
Interest income	(2.8)	(1.9)	(7.8)	(6.8)
Interest expense, net of capitalized interest	5.1	11.2	17.1	36.2
Loss on Wafer Supply Agreement	0.5	0.1	1.4	0.1
Loss on early payment of transaction-related note receivable (2)	1.2	—	1.2	—
Other, net	0.1	(0.2)	(0.1)	0.1
Non-operating expense, net	$3.8	$8.1	$35.7	$18.9

(1) As discussed further in Note 9, "Long-term Debt," in the second quarter of fiscal 2022, all outstanding 0.875% convertible senior notes due September 1, 2023 (the 2023 Notes) were surrendered for conversion, resulting in the settlement of all outstanding 2023 Notes in shares, with fractional shares paid in cash.

(2) As discussed further in Note 2, "Discontinued Operations," in the third quarter of fiscal 2022, the Company recognized a loss of $1.2 million related to the early payment for the Purchase Price Note.


	Nine months ended
(in millions of U.S. Dollars)	March 27, 2022	March 28, 2021
Lease asset and liability additions	$6.3	$1.7
Lease asset and liability modifications, net	3.3	0.3
Lease terminations	(0.2)	—
Transfer of finance lease liability to accounts payable and accrued expenses (1)	—	4.2
Settlement of 2023 Notes in shares of common stock (2)	416.1	—
Decrease in property, plant and equipment from long-term incentive related receivables	137.3	—

(1) In the first quarter of fiscal 2021, the Company executed the available bargain purchase option for certain finance leases relating to property and equipment, net, in order to purchase the assets.

(2) As discussed further in Note 9, "Long-term Debt," in the second quarter of fiscal 2022, all outstanding 2023 Notes were surrendered for conversion, resulting in the settlement of all outstanding 2023 Notes in shares, with fractional shares paid in cash.